People · Operator
Named in public records as an officer, director or promoter · active 2009–2009 · Biotechnology
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Cell Biosciences Inc | — | Biotechnology | Series B | $62.3M | $516.0M | 2009 |
Julie Blaine Eskay-Eagle at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Julie Blaine Eskay-Eagle on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| James Blair | 1 | 8 |
| David Barker | 1 | 7 |
| James Woody | 1 | 4 |
| Julie Eskay-Eagle | 1 | 3 |
| James Blaine Woody | 1 | 1 |
| Timothy Harkness | 1 | 1 |
| James Blaine Novi | 1 | 1 |
| Jack Nielson | 1 | 1 |
| Ron Blaine Eastman | 1 | 1 |
| James Novi | 1 | 1 |
| A. Blaine Bowman | 1 | 1 |
| Jason Blaine Novi | 1 | 1 |
| Jack Blaine Nielson | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.